Fenofibrate Capsules
- All
- News
-
Lupin, Eicher Motors, Bata India Among Stocks In Focus In Muhurat Session
Lupin announced launch of authorized generic version of Antara Fenofibrate capsules, 30 mg and 90 mg
-
Ranbaxy Gets US Regulator Nod to Sell Cholesterol Medicine
Drug firm Ranbaxy Laboratories has received approval from the US Food nad Drug Administration (FDA) for manufacturing and marketing Fenofibrate capsules used for lowering high cholesterol and triglyceride levels in the blood.
-
Dr Reddy's launches lipid control drug in US
Pharma major Dr. Reddy's Laboratories (DRL) on Wednesday said it has launched Fenofibrate capsules, a therapeutic equivalent generic version of Antara capsules, in the US market.
-
Lupin launches generic Fenofibric Acid capsules in US market
Lupin Pharmaceuticals Inc (LPI), the company's US subsidiary has launched its generic Fenofibric Acid Delayed- release capsules in the strengths of 45 mg and 135 mg, Lupin Ltd said in a statement.
-
Lupin gets US regulator's nod for additional strengths of cholesterol drug
The company has received final approval for its supplemental New Drug Application (sNDA) for Antara (Fenofibrate) capsules in 30 mg and 90 mg strengths from the United States Food and Drug Administration (USFDA), Lupin Ltd said in a statement.
-
Lupin, Eicher Motors, Bata India Among Stocks In Focus In Muhurat Session
Lupin announced launch of authorized generic version of Antara Fenofibrate capsules, 30 mg and 90 mg
-
Ranbaxy Gets US Regulator Nod to Sell Cholesterol Medicine
Drug firm Ranbaxy Laboratories has received approval from the US Food nad Drug Administration (FDA) for manufacturing and marketing Fenofibrate capsules used for lowering high cholesterol and triglyceride levels in the blood.
-
Dr Reddy's launches lipid control drug in US
Pharma major Dr. Reddy's Laboratories (DRL) on Wednesday said it has launched Fenofibrate capsules, a therapeutic equivalent generic version of Antara capsules, in the US market.
-
Lupin launches generic Fenofibric Acid capsules in US market
Lupin Pharmaceuticals Inc (LPI), the company's US subsidiary has launched its generic Fenofibric Acid Delayed- release capsules in the strengths of 45 mg and 135 mg, Lupin Ltd said in a statement.
-
Lupin gets US regulator's nod for additional strengths of cholesterol drug
The company has received final approval for its supplemental New Drug Application (sNDA) for Antara (Fenofibrate) capsules in 30 mg and 90 mg strengths from the United States Food and Drug Administration (USFDA), Lupin Ltd said in a statement.
